Alteration in amyloid β42, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid β42 with changes in glucose metabolism.
BACKGROUND
Diabetes accelerates memory dysfunction in a continuous, slowly pathological process. Studies suggest that the time course of certain biomarkers can characterize the pathological course of the disease to provide information for early intervention. Thus, there is an urgent need for validated biomarkers to characterize the cognitive impairment induced by DM. We aimed to detect changes in cerebrospinal fluid biomarkers such as amyloid β42, phosphorylated tau protein, interleukin 6, and acetylcholine in diabetic rats over time, and to analyse the relationship between diabetes and cognitive impairment.


METHODS
Rats were injected once intraperitoneally with 1% of streptozotocin to establish a diabetic model. Index changes were investigated longitudinally and all were measured at the end of the experiment at day 75. Aβ42, P-tau, IL-6, and ACh levels in CSF, insulin levels in plasma, and Aβ42 levels in plasma and brain tissue were measured by ELISA.


RESULTS
Compared with control, the diabetic model showed ACh in CSF to be decreased by day 15, continuing lower out to day 75. Aβ42 changes in brain and blood showed the same trends but exhibited minima at different time points: day 30 in CSF and day 15 in plasma. After the minimum, Aβ42 in cerebrospinal fluid rose and levelled off lower than in the control group, whereas Aβ42 in plasma rose and went above the controls at day 30, slowly trending upwards for the remainder of the experiment. P-tau protein in CSF in diabetic rats showed an increasing trend, becoming significantly different from the controls at day 60 and day 75. Aβ42 in CSF was strongly negatively correlated with blood glucose at day 15 and was negatively correlated with insulin in serum, particularly at day 45.


CONCLUSIONS
Our longitudinal research model suggest that changes in the measured biomarkers appear before learning and memory impairments do. Aβ42 and ACh in the diabetes model group clearly changed from day 0 to day 45, and then P-tau and IL-6 varied significantly from day 45 to day 75. The reduced ACh levels observed possibly correlated with the factors common to changes in Aβ42, P-tau, and IL-6.
College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, 150076, China. zhouyou1199@163.com.
You
Y
Zhou
College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, 150076, China. yingzhao16@yahoo.com.
Ying
Y
Zhao
College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, 150076, China. 59116830@qq.com.|College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, China. 59116830@qq.com.
Hailong
H
Xie
College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, 150076, China. 1257760518@qq.com.
Yan
Y
Wang
College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, 150076, China. liulinyx@163.com.
Lin
L
Liu
College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, 150076, China. 32179377@qq.com.
Xinjia
X
Yan
D000109:Acetylcholine / Q000134:cerebrospinal fluid; D016229:Amyloid beta-Peptides / Q000097:blood / Q000378:metabolism*; D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D003071:Cognition; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005947:Glucose / Q000378:metabolism*; D007328:Insulin / Q000097:blood; D015850:Interleukin-6 / Q000097:blood / Q000134:cerebrospinal fluid; D008137:Longitudinal Studies; D008297:Male; D008569:Memory Disorders / Q000378:metabolism*; D010446:Peptide Fragments / Q000097:blood / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D016875:tau Proteins / Q000097:blood / Q000134:cerebrospinal fluid
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D007328:Insulin; D015850:Interleukin-6; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D016875:tau Proteins; D005947:Glucose; D000109:Acetylcholine